Moderna’s COVID-19 mRNA vaccine trial was one of the most diverse clinical trials in history. LaQuinta Jernigan, Executive Vice President for the Americas at mdgroup and Jameka Hill, Director of Patient Engagement and Advocacy and Clinical Trial Diversity at Moderna, discuss why diversity in vaccine trials matters, the ways Moderna achieved diversity and inclusion, and the lasting legacy of this commitment to diversity within the clinical research industry.